Alzheimer's research and help, in plain English.
Straight answers for families facing Alzheimer's.
Or tell us where you are
Latest news
Approvals, trial results and policy changes, from established outlets.
-
Brain scans reveal two regions that shrink before the hippocampus in Alzheimer's
Johns Hopkins University researchers have identified two areas of the brain that show significant signs of Alzheimer's disease before it reaches the hippocampus, possibly providing new biomarkers that could get people diagnosed and started on treatment before symptoms begin…
-
Daytime brain waves resembling deep sleep could explain hallucinations in Parkinson's disease
Parkinson's disease is a progressive brain disorder that damages dopamine-producing neurons, causing symptoms to worsen over time.
-
Researchers find potential way to protect the brain from HIV and opioid damage
People living with HIV continue to struggle with memory loss, difficulty concentrating and poor decision-making, even as antiretroviral treatments have dramatically improved life expectancy. …
-
Parkinson's Disease Linked to Agent Orange Exposure
(MedPage Today) -- Vietnam-era military veterans exposed to the weedkiller Agent Orange had a higher risk of developing Parkinson's disease and other neurodegenerative synucleinopathies, a study of more than 4 million Veterans Affairs (VA) health...
-
An Intriguing Approach to Slow Alzheimer’s Shows Mixed Results
The device, a headset delivering light and sound, is based on the theory that audiovisual stimulation can evoke brainwave responses that might help preserve neurological function.
Latest research
The newest studies in the library that score 67 or more out of 100 (2,888 of the 32,580 do), with their peer-review status.
-
Avoidable Mortality in Adults With Down Syndrome or With Other Intellectual Disabilities
Among 3381 adults with Down syndrome (1892 male [56.0%]; median [IQR] age at death, 59.5 [54.3-64.2] years), 1589 (47.0%) died from avoidable causes. (+4 more on the study page)
-
Evaluating a primary care pharmacist-led intervention to reduce opioid use for persistent non-cancer pain: the PROMPPT cluster randomised controlled trial protocol
The PROMPPT trial will assess whether review by trained clinical pharmacists working in general practices can support safe opioid reduction without compromising pain management and quality of life. (+1 more on the study page)
-
Real-world safety and efficacy of lecanemab in the treatment of Alzheimer's disease: a systematic review and meta-analysis
Thirty-seven studies were included. (+3 more on the study page)
-
Baseline MRI markers and clinical outcomes during anti-amyloid β therapy: A real-world study in a Japanese dementia center
Baseline medial temporal atrophy was associated with functional decline and microbleeds with ARIA-H. Pretreatment MRI may provide prognostic and safety information during anti-amyloid β therapy. (+4 more on the study page)
-
Midlife and Late-Life Alzheimer Disease Blood Biomarkers and 11-Year Cognitive Decline
Midlife p-tau181 was associated with faster 11-year memory decline beginning 20 years later in the ARIC cohort, which underscores a potentially long prodromal phase of cognitive decline that could precede dementia onset. (+4 more on the study page)
The research library
32,580 studies in plain English across 32 subjects. Each is scored and links to the original paper.
Search and filter the research →
Browse by subject · Links the news suggests that nobody has tested · Conferences and events
A few key figures
Americans age 65+ living with Alzheimer's dementia
Alzheimer's Association, 2025 Alzheimer's Disease Facts and Figures (Alzheimer's & Dementia)Alzheimer's prevalence by age: 85+
Alzheimer's Association, 2025 Facts and FiguresIncrease in U.S. Alzheimer's deaths, 2000-2022
Alzheimer's Association, 2025 Facts and FiguresFamily/unpaid dementia caregivers in the U.S.
Alzheimer's Association, 2026 Alzheimer's Disease Facts and FiguresDementia caregivers who rated emotional stress of caregiving as high or very high
Alzheimer's Association, 2025 Facts and FiguresLifetime cost of care per person with dementia
Alzheimer's Association, 2025 Facts and FiguresPeople living with dementia worldwide
WHO, Dementia Fact SheetShare of dementia cases potentially preventable/delayable via modifiable risk factors
Livingston G, Huntley J, Liu KY, et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. Lancet 2024;404(10452):572-628, Table 1FDA-cleared Lumipulse blood test accuracy for detecting amyloid pathology
FDA press announcement, Lumipulse G pTau217/Beta-Amyloid 1-42 Plasma Ratio clearanceWhat the research library says
Each page below is built from the studies in alzhub's library: how many match, what kinds of study they are, and what the papers report in their own words.